BRYN MAWR TRUST Co Lowers Holdings in Masimo Corporation (MASI)
BRYN MAWR TRUST Co cut its position in Masimo Corporation (NASDAQ:MASI) by 1.3% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 112,570 shares of the medical equipment provider’s stock after selling 1,458 shares during the quarter. BRYN MAWR TRUST Co owned about 0.22% of Masimo Corporation worth $10,265,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of the business. BlackRock Inc. raised its stake in shares of Masimo Corporation by 7.5% in the second quarter. BlackRock Inc. now owns 7,915,230 shares of the medical equipment provider’s stock valued at $721,710,000 after buying an additional 550,995 shares during the period. Vanguard Group Inc. raised its stake in shares of Masimo Corporation by 5.9% in the first quarter. Vanguard Group Inc. now owns 4,617,633 shares of the medical equipment provider’s stock valued at $430,641,000 after buying an additional 258,719 shares during the period. Acadian Asset Management LLC raised its stake in shares of Masimo Corporation by 28.0% during the 2nd quarter. Acadian Asset Management LLC now owns 1,791,597 shares of the medical equipment provider’s stock valued at $163,356,000 after purchasing an additional 392,410 shares during the period. State Street Corp raised its stake in shares of Masimo Corporation by 42.8% during the 1st quarter. State Street Corp now owns 1,401,516 shares of the medical equipment provider’s stock valued at $130,704,000 after purchasing an additional 419,767 shares during the period. Finally, Robeco Institutional Asset Management B.V. raised its stake in shares of Masimo Corporation by 27.1% during the 2nd quarter. Robeco Institutional Asset Management B.V. now owns 1,095,353 shares of the medical equipment provider’s stock valued at $99,872,000 after purchasing an additional 233,412 shares during the period. Hedge funds and other institutional investors own 83.21% of the company’s stock.
In other Masimo Corporation news, Director Sanford Fitch sold 6,000 shares of the firm’s stock in a transaction dated Thursday, July 13th. The stock was sold at an average price of $91.89, for a total transaction of $551,340.00. Following the sale, the director now directly owns 89,249 shares of the company’s stock, valued at $8,201,090.61. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Jon Coleman sold 25,000 shares of the firm’s stock in a transaction dated Thursday, July 20th. The shares were sold at an average price of $97.50, for a total value of $2,437,500.00. Following the sale, the insider now directly owns 32,201 shares in the company, valued at $3,139,597.50. The disclosure for this sale can be found here. Over the last three months, insiders have sold 126,000 shares of company stock worth $11,732,930. Insiders own 16.60% of the company’s stock.
Masimo Corporation (NASDAQ MASI) traded up 0.36% during mid-day trading on Monday, hitting $85.89. The company had a trading volume of 92,897 shares. The firm’s 50 day moving average is $86.35 and its 200 day moving average is $91.07. Masimo Corporation has a 52 week low of $53.78 and a 52 week high of $104.71. The company has a market capitalization of $4.46 billion, a price-to-earnings ratio of 14.08 and a beta of 0.84.
Masimo Corporation (NASDAQ:MASI) last announced its earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.83 EPS for the quarter, topping the Zacks’ consensus estimate of $0.71 by $0.12. The company had revenue of $192.90 million for the quarter, compared to analysts’ expectations of $189.03 million. Masimo Corporation had a return on equity of 23.45% and a net margin of 45.90%. Masimo Corporation’s revenue for the quarter was up 11.8% compared to the same quarter last year. During the same period last year, the firm earned $0.57 EPS. On average, equities research analysts predict that Masimo Corporation will post $2.80 EPS for the current year.
TRADEMARK VIOLATION WARNING: “BRYN MAWR TRUST Co Lowers Holdings in Masimo Corporation (MASI)” was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this news story on another publication, it was copied illegally and republished in violation of international copyright law. The original version of this news story can be viewed at https://www.thecerbatgem.com/2017/09/18/bryn-mawr-trust-co-lowers-holdings-in-masimo-corporation-masi.html.
A number of research firms recently issued reports on MASI. Wedbush reiterated an “outperform” rating and set a $112.00 price objective on shares of Masimo Corporation in a research note on Monday, May 22nd. BidaskClub upgraded Masimo Corporation from a “hold” rating to a “buy” rating in a research note on Wednesday, July 12th. Stifel Nicolaus began coverage on Masimo Corporation in a research note on Monday, July 10th. They set a “buy” rating and a $105.00 price objective on the stock. Roth Capital boosted their price objective on Masimo Corporation from $96.00 to $105.00 and gave the company a “buy” rating in a research note on Wednesday, July 19th. Finally, BTIG Research upgraded Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a research note on Monday, August 14th. One analyst has rated the stock with a sell rating, four have issued a hold rating and four have issued a buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of $95.00.
Masimo Corporation Profile
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Receive News & Stock Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related stocks with our FREE daily email newsletter.